Roche: FDA approves drug combo Venclexta plus Gazyva for previously untreated chronic lymphocytic leukemia
Roche said on Thursday that the U.S. Food and Drug Administration had approved a treatment using its drugs Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukemia.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Chronic Leukemia | Chronic Lymphocytic Leukemia | Food and Drug Administration (FDA) | Health | Leukemia